UnknownPhase 3

Preventing Acute Kidney Injury (AKI) in Pediatric Patients

United States80 participantsStarted 2019-02-07

Plain-language summary

The purpose of this study is to compare the effects of peri-operative administration of Aminophylline versus Saline placebo in the preservation of renal function and the attenuation of renal injury in pediatric patients undergoing open heart surgery.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Cohort 1 * All children undergoing open heart surgery for congenital heart defects with or without circulatory arrest * Neonates (\<28 days old) and infants (\<1 years of age) * Hypoplastic L heart syndrome or its variants. * Coarctation with aortic arch hypoplasia. * Interrupted aortic arch. * TAPVR (Total anomalous pulmonary venous return) * Patients with complex congenital heart defects Cohort 2: * Orthotopic heart transplantation patients. * Patients ≤ 18 years of age * Congenital heart defects * Cardiomyopathy (Dilated/Hypertrophic/Restrictive/Left Ventricular Non-compaction) Exclusion Criteria: * Children under the age of 12 months undergoing bypass for any condition that is not categorized as congenital heart defect * History of seizures * History of significant tachyarrhythmia.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Acute kidney injury state II/III by AKIN criteria

Timeframe: At 48 hours post-operative

Trial details

NCT IDNCT03897335

SponsorLe Bonheur Children's Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-02-01

Contact for this trial

Lauren Davis

901-287-4594 lauren.davis2@lebonheur.org

View on ClinicalTrials.gov More Acute Kidney Injury trials

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.